Clinical Trials of Texas, Inc   Report issue

For profit Phase 2 Phase 3
Founded: San Antonio TX United States (2001)

Organization Overview

First Clinical Trial
2010
NCT01188928
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Clinical Trials of Texas, Inc. 7940 Floyd Curl drive, Suite 700, San Antonio, Texas 78229

Active Ingredients

Drugs in Phase 3 Trials (2)

betamethasone (celestone) (1 trial)

calcipotriene (dovonex) (1 trial)

Drugs in Phase 2 Trials (2)

allogeneic plx-pad cells (1 trial)

san021 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intermittent Claudication (Phase 2)

Peripheral Arterial Disease (Phase 2)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4